QA: Optinose Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001494650_2023_Optinose_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001494650, Optinose Inc

  xvar xval
0 AssetsCurrent 140,484,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 795,000
3 remainder_Assets 2,943,000
4 LiabilitiesCurrent 178,730,000
5 LiabilitiesNoncurrent 626,000
6 remainder_Liabilities 21,490,000
7 CostOfGoodsAndServicesSold 9,520,823
8 SellingGeneralAndAdministrativeExpense 108,634,860
9 ResearchAndDevelopmentExpense 18,048,624
10 remainder_Expenses 17,171,166
11 remainder_Revenues 75,081,162
12 remainder_NetIncome -382,855
13 remainder_ComprehensiveNetIncome 170
  yvar yval
0 Assets 144,222,000
1 Liabilities 200,846,000
2 Expenses 153,375,473
3 Revenues 75,081,162
4 StockholdersEquity -56,624,000
5 NetIncome -78,677,166
6 ComprehensiveNetIncome -78,677,081
7 BaseVar 286,953,830
8 EconomicCapitalRatiobeforeLimitedLiability -1.17
9 EconomicCapitalRatio 1.26

Edgar->Model Mapping

Feature Distribution

Change over Time